EMC Instytut Medyczny SA (EMC) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Jun 2023)

FII

90.58%

Held by 1 FIIs

DII

9.07%

Held by 4 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROCE of 1.36%

The company has been able to generate a Return on Capital Employed (avg) of 1.36% signifying low profitability per unit of total capital (equity and debt)

High Debt Company with a Debt to Equity ratio (avg) at 0 times

Flat results in Dec 24

With ROE of 6.7, it has a very expensive valuation with a 2.2 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Hospital/Nursing Management

Market cap

PLN 470 Million (Micro Cap)

P/E

32.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.18

Return on Equity

6.69%

Price to Book

2.15

Revenue and Profits:

Net Sales:

215 Million

(Quarterly Results - Dec 2024)

Net Profit:

3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-4.35%

6 Months

6.8%

1 Year

4.76%

2 Years

19.57%

3 Years

-3.51%

4 Years

-21.43%

5 Years

58.27%

EMC Instytut Medyczny SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

17.12%

EBIT Growth (5y)

28.44%

EBIT to Interest (avg)

-0.03

Debt to EBITDA (avg)

1.85

Net Debt to Equity (avg)

0.18

Sales to Capital Employed (avg)

2.51

Tax Ratio

24.11%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.36%

ROE (avg)

3.07%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.15

EV to EBIT

39.47

EV to EBITDA

11.30

EV to Capital Employed

1.97

EV to Sales

0.63

PEG Ratio

Dividend Yield

ROCE (Latest)

5.00%

ROE (Latest)

6.69%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2023

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (90.58%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 22.69% vs 15.93% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -43.48% vs 666.67% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "215.20",
          "val2": "175.40",
          "chgp": "22.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.40",
          "val2": "5.30",
          "chgp": "39.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "1.30",
          "chgp": "-84.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.60",
          "val2": "4.60",
          "chgp": "-43.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5.10%",
          "val2": "-22.10%",
          "chgp": "1.70%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.65% vs 18.62% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -15.61% vs 383.61% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "809.40",
          "val2": "682.20",
          "chgp": "18.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49.60",
          "val2": "40.70",
          "chgp": "21.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.00",
          "val2": "5.80",
          "chgp": "3.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.60",
          "val2": "10.40",
          "chgp": "-65.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.60",
          "val2": "17.30",
          "chgp": "-15.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.50%",
          "val2": "12.40%",
          "chgp": "0.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY

Dec'24

Dec'23

Change(%)

Net Sales

215.20

175.40

22.69%

Operating Profit (PBDIT) excl Other Income

7.40

5.30

39.62%

Interest

0.20

1.30

-84.62%

Exceptional Items

0.00

Consolidate Net Profit

2.60

4.60

-43.48%

Operating Profit Margin (Excl OI)

-5.10%

-22.10%

1.70%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2024 is 22.69% vs 15.93% in Dec 2023

Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -43.48% vs 666.67% in Dec 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

809.40

682.20

18.65%

Operating Profit (PBDIT) excl Other Income

49.60

40.70

21.87%

Interest

6.00

5.80

3.45%

Exceptional Items

3.60

10.40

-65.38%

Consolidate Net Profit

14.60

17.30

-15.61%

Operating Profit Margin (Excl OI)

21.50%

12.40%

0.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 18.65% vs 18.62% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -15.61% vs 383.61% in Dec 2023

All Annual Results

Company CV

About EMC Instytut Medyczny SA

EMC Instytut Medyczny SA

Hospital/Nursing Management

EMC Instytut Medyczny SA is a Poland-based company that operates a network of private hospitals and health centers in Poland and in Ireland. The Company offers a range of services, including the professional treatment of obesity, hernia, knee surgery, hip replacement and various plastic surgeries. It also provides such diagnostic services as laboratory tests, diagnostic imaging (X-ray and ultrasonography), colonoscopy, gastroscopy and capsule endoscopy, as well as consultancy services with a range of specialists. In addition, it provides the prophylaxis programs. The Company operates hospitals and outpatient specialty and care clinics. It operates such subsidiaries as: Lubmed Sp z o o, Mikulicz Sp z o o, EMC Silesia Sp z o o, PCZ Kowary Sp z o o and EMC Health Care Limited, among others. On January 3, 2014, CareUp BV acquired 68.41% stake in the Company due to the acquisition of Soporto Invest BV. On February 11, 2014, the Company acquired Regionalne Centrum Zdrowia Sp z o o.

Company Coordinates

Company Details

UL. PILCZYCKA 144-148 , WROCLAW None : 54-144

Tel: 48 71 7472700

http://www.emc-sa.pl

Registrar Details